News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
318,865 Results
Type
Article (19943)
Company Profile (321)
Press Release (298595)
Multimedia
Podcasts (83)
Webinars (11)
Section
Business (86834)
Career Advice (251)
Deals (14459)
Drug Delivery (40)
Drug Development (58937)
Employer Resources (39)
FDA (7003)
Job Trends (6182)
News (162345)
Policy (12481)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1300)
Accelerated approval (23)
Adcomms (19)
Allergies (98)
Alliances (23940)
ALS (132)
Alzheimer's disease (1132)
Antibody-drug conjugate (ADC) (255)
Approvals (7193)
Artificial intelligence (292)
Autoimmune disease (140)
Automation (14)
Bankruptcy (118)
Best Places to Work (5530)
BIOSECURE Act (6)
Biosimilars (113)
Biotechnology (249)
Bladder cancer (131)
Brain cancer (48)
Breast cancer (386)
Cancer (3702)
Cardiovascular disease (247)
Career advice (212)
Career pathing (7)
CAR-T (259)
CDC (48)
Cell therapy (650)
Cervical cancer (19)
Clinical research (50222)
Collaboration (1243)
Company closure (2)
Compensation (657)
Complete response letters (45)
COVID-19 (2012)
CRISPR (89)
C-suite (585)
Cystic fibrosis (117)
Data (4942)
Denatured (16)
Depression (94)
Diabetes (284)
Diagnostics (1750)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (11)
Drug discovery (206)
Drug pricing (51)
Drug shortages (4)
Duchenne muscular dystrophy (220)
Earnings (34474)
Editorial (30)
Employer branding (5)
Employer resources (35)
Events (57313)
Executive appointments (647)
FDA (8983)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1064)
Gene editing (189)
Generative AI (25)
Gene therapy (521)
GLP-1 (539)
Government (1924)
Grass and pollen (4)
Guidances (190)
Healthcare (7863)
HIV (33)
Huntington's disease (43)
IgA nephropathy (81)
Immunology and inflammation (238)
Immuno-oncology (56)
Indications (79)
Infectious disease (2232)
Inflammatory bowel disease (177)
Inflation Reduction Act (10)
Influenza (85)
Intellectual property (173)
Interviews (38)
IPO (8019)
IRA (13)
Job creations (987)
Job search strategy (189)
JPM (40)
Kidney cancer (12)
Labor market (26)
Layoffs (279)
Leadership (9)
Legal (1593)
Liver cancer (52)
Longevity (12)
Lung cancer (521)
Lymphoma (318)
Machine learning (30)
Management (10)
Manufacturing (422)
MASH (130)
Medical device (2836)
Medtech (2846)
Mergers & acquisitions (7102)
Metabolic disorders (784)
Multiple sclerosis (133)
NASH (13)
Neurodegenerative disease (246)
Neuropsychiatric disorders (71)
Neuroscience (2113)
Neurotech (1)
NextGen: Class of 2026 (2306)
Non-profit (1157)
Now hiring (30)
Obesity (349)
Opinion (131)
Ovarian cancer (145)
Pain (113)
Pancreatic cancer (180)
Parkinson's disease (243)
Partnered (13)
Patents (330)
Patient recruitment (361)
Peanut (50)
People (28554)
Pharmaceutical (48)
Pharmacy benefit managers (9)
Phase 1 (17549)
Phase 2 (23099)
Phase 3 (15158)
Pipeline (3694)
Policy (136)
Postmarket research (1076)
Preclinical (7404)
Press Release (38)
Prostate cancer (160)
Psychedelics (50)
Radiopharmaceuticals (241)
Rare diseases (701)
Real estate (1617)
Recruiting (15)
Regulatory (11798)
Reports (21)
Research institute (1363)
Resumes & cover letters (37)
Rett syndrome (25)
RNA editing (21)
RSV (70)
Schizophrenia (123)
Series A (192)
Series B (147)
Service/supplier (1)
Sickle cell disease (79)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (18)
Startups (2098)
State (1)
Stomach cancer (12)
Supply chain (40)
Tariffs (24)
The Weekly (66)
Vaccines (872)
Venture capital (71)
Weight loss (187)
Women's health (29)
Worklife (2)
Date
Today (82)
Last 7 days (381)
Last 30 days (1378)
Last 365 days (19894)
2026 (1973)
2025 (20109)
2024 (22649)
2023 (24970)
2022 (30103)
2021 (31799)
2020 (27181)
2019 (18452)
2018 (13496)
2017 (15592)
2016 (13582)
2015 (16246)
2014 (11737)
2013 (8491)
2012 (8557)
2011 (8517)
2010 (8206)
Location
Africa (217)
Alabama (65)
Alaska (2)
Arizona (76)
Arkansas (5)
Asia (20619)
Australia (3679)
California (7720)
Canada (1966)
China (828)
Colorado (277)
Connecticut (280)
Delaware (272)
Europe (44939)
Florida (1008)
Georgia (237)
Hawaii (3)
Idaho (19)
Illinois (445)
India (38)
Indiana (272)
Iowa (14)
Japan (245)
Kansas (82)
Kentucky (12)
Louisiana (7)
Maine (57)
Maryland (828)
Massachusetts (5993)
Michigan (114)
Minnesota (254)
Mississippi (3)
Missouri (40)
Montana (19)
Nebraska (7)
Nevada (47)
New Hampshire (22)
New Jersey (1967)
New Mexico (14)
New York (2022)
North Carolina (867)
North Dakota (6)
Northern California (3817)
Ohio (188)
Oklahoma (12)
Oregon (25)
Pennsylvania (1372)
Puerto Rico (10)
Rhode Island (27)
South America (266)
South Carolina (9)
Southern California (3035)
Tennessee (44)
Texas (988)
United States (25800)
Utah (106)
Virginia (172)
Washington D.C. (40)
Washington State (654)
West Virginia (1)
Wisconsin (51)
318,865 Results for "immune therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
January 20, 2026
·
3 min read
Press Releases
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
September 15, 2025
·
7 min read
Press Releases
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
November 19, 2025
·
11 min read
Press Releases
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
January 8, 2026
·
4 min read
Press Releases
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases
October 27, 2025
·
7 min read
Press Releases
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
December 4, 2025
·
8 min read
Press Releases
Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer
December 23, 2025
·
4 min read
Press Releases
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
January 7, 2026
·
12 min read
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
The reprioritization effort will help AC Immune extend its cash runway through the third quarter of 2027.
September 4, 2025
·
2 min read
·
Tristan Manalac
1 of 31,887
Next
